Physician profile
Harishanker Jeyarajan
NPI 1477911816
$149,788.46
in general payments reported to CMS, 2019-2025
27 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,040 · 2020: $1,189 · 2021: $2,620 · 2022: $9,782 · 2023: $12K · 2024: $77K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $85K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $85,125.70 |
| Travel and Lodging | $15,828.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,000.00 |
| Food and Beverage | $12,202.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $130,866.27 | 2019-2025 | Da Vinci Surgical System |
| Stryker Corporation | $5,322.81 | 2021-2025 | 1688, Na, Delta |
| Axogen | $3,101.86 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Smith+Nephew, INC. | $2,611.63 | 2020-2025 | Renasys Go V2 Home, Grafix Pl, Halo |
| Medtronic, INC. | $1,518.20 | 2022-2025 | Propel, Midas Rex |
| Integra Lifesciences Corporation | $1,023.64 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Zimmer Biomet Holdings, INC. | $1,022.30 | 2019-2022 | |
| Depuy Synthes Sales INC. | $777.82 | 2020-2021 | |
| Angiodynamics, INC. | $692.23 | 2023-2025 | Nanoknife |
| Aroa Biosurgery Incorporated | $579.26 | 2023-2024 | |
| 3-D Matrix, INC. | $415.54 | 2025 | |
| Polarityte, INC. | $232.22 | 2019-2020 | |
| Inspire Medical Systems, INC. | $219.51 | 2019-2023 | Inspire |
| Convatec INC. | $211.76 | 2025 | |
| Steris Corporation | $195.37 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $167.24 | 2023 | Fiberlase Co2 Fiber |
| Ethicon US, LLC | $145.25 | 2025 | Harmonic, Enseal |
| Bsn Medical INC | $127.32 | 2025 | |
| Mauna Kea Technologies, INC. | $124.24 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2024 | Libtayo |
| Neurent Medical Limited | $99.16 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Kls-Martin L.P. | $78.76 | 2024 | |
| Oticon Medical, LLC | $43.01 | 2021 | |
| Reapplix INC. | $26.16 | 2025 | 3c Patch Kit - Box |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
| Hologic Sales and Service, LLC | $25.55 | 2024 | Coolseal Generator |
| Cook Medical LLC | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harishanker Jeyarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.